HomeRGNX • NASDAQ
add
Regenxbio Inc
Previous close
$9.38
Day range
$8.94 - $9.31
Year range
$5.04 - $16.19
Market cap
465.03M USD
Avg Volume
1.17M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 30.34M | 43.00% |
Operating expense | 22.43M | 41.24% |
Net income | -67.15M | -31.19% |
Net profit margin | -221.34 | 8.26% |
Earnings per share | -1.30 | -28.71% |
EBITDA | -53.77M | -13.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 230.07M | -1.97% |
Total assets | 453.03M | -2.78% |
Total liabilities | 350.30M | 69.77% |
Total equity | 102.73M | — |
Shares outstanding | 51.61M | — |
Price to book | 4.64 | — |
Return on assets | -29.46% | — |
Return on capital | -36.35% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -67.15M | -31.19% |
Cash from operations | -52.29M | -65.35% |
Cash from investing | 37.54M | -6.79% |
Cash from financing | -9.58M | -23.82% |
Net change in cash | -24.34M | -2,777.23% |
Free cash flow | -28.98M | -59.19% |
About
Founded
2008
Headquarters
Website
Employees
371
